CAS number：2012536-16-0 molecular formula：C14H23N3O4
NYX-2925 is an orally active NMDAR modulator. NYX-2925 restores levels of activated Src and Src phosphorylation sites on GluN2A and GluN2B in the mPFC. NYX-2925 shows no effect on CAMKII, and any addictive or sedative/ataxic side effects. NYX-2925 can be used for research of a variety of NMDA receptor-mediated central nervous system disorders IC50& Target:NMDA Receptor
| Chinese alias | - | ||
| English alias | 2012536-16-0 | NYX2925 | NYX-2925 | 2,5-DIAZASPIRO(3.4)OCTANE-2-ACETAMIDE, .ALPHA.-((1R)-1-HYDROXYETHYL)-5-(2-METHYL-1-OXOPROPYL)-1-OXO-, (.ALPHA.S,4R)- | (2S,3R)-3-hydroxy-2-[(4R)-5-(2-methylpropanoyl)-3-oxo-2,5-diazaspiro[3.4]octan-2-yl]butanamide | X06 | ||
| CAS number | 2012536-16-0 | molecular formula | C14H23N3O4 |
| molecular weight | 297.35 g/mol | Exact mass | - |
| PSA | - | logp | - |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
